Narcolepsy and influenza A (H1N1) pandemic 2009 vaccination in the United States

J Duffy, E Weintraub, C Vellozzi, F DeStefano - Neurology, 2014 - AAN Enterprises
Objective: To assess the occurrence of narcolepsy after influenza vaccines used in the
United States that contained the influenza A (H1N1) pdm09 virus strain. Methods: A …

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice

R Nachbagauer, D Kinzler, A Choi, A Hirsh, E Beaulieu… - npj Vaccines, 2016 - nature.com
Seasonal influenza virus vaccines are generally effective at preventing disease, but need to
be well matched to circulating virus strains for maximum benefit. Influenza viruses constantly …

Inactivated and adjuvanted influenza vaccines

G Del Giudice, R Rappuoli - Influenza Pathogenesis and Control-Volume II, 2014 - Springer
Inactivated influenza vaccines are produced every year to fight against the seasonal
epidemics of influenza. Despite the nonoptimal coverage, even in subjects at risk like the …

[HTML][HTML] Challenges and responses in human vaccine development

SHE Kaufmann, MJ McElrath, DJM Lewis… - Current opinion in …, 2014 - Elsevier
Highlights•Reverse, structural and synthetic vaccinology to accelerate novel vaccine
design.•Systems analysis of multiparametric data to predict reactogenicity and …

A comprehensive overview on the production of vaccines in plant-based expression Systems and the scope of Plant Biotechnology to Combat against SARS-CoV-2 …

M Kumar, N Kumari, N Thakur, SK Bhatia, GD Saratale… - Plants, 2021 - mdpi.com
Many pathogenic viral pandemics have caused threats to global health; the COVID-19
pandemic is the latest. Its transmission is growing exponentially all around the globe, putting …

[HTML][HTML] Molecular signatures of vaccine adjuvants

T Olafsdottir, M Lindqvist, AM Harandi - Vaccine, 2015 - Elsevier
Mass vaccination has saved millions of human lives and improved the quality of life in both
developing and developed countries. The emergence of new pathogens and inadequate …

Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV …

SC De Rosa, KW Cohen, M Bonaparte… - Clinical & …, 2022 - Wiley Online Library
Objectives We previously described the Phase I‐II evaluation of SARS‐CoV‐2 recombinant
protein candidate vaccine, CoV2‐PreS‐dTM, with AF03‐or AS03‐adjuvant systems …

Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases

JW Lim, YR Ahn, G Park, HO Kim, S Haam - Pharmaceutics, 2021 - mdpi.com
The coronavirus disease (COVID-19) pandemic poses serious global health concerns with
the continued emergence of new variants. The periodic outbreak of novel emerging and re …

AF03, an alternative squalene emulsion‐based vaccine adjuvant prepared by a phase inversion temperature method

MF Klucker, F Dalençon, P Probeck… - Journal of pharmaceutical …, 2012 - Elsevier
ABSTRACT AF03 is a squalene‐based emulsion adjuvant that is present in the adjuvanted
pandemic influenza vaccine, Humenza™. In this report, we describe the design and …

Towards precision vaccines: lessons from the second international precision vaccines conference

D Soni, SD Van Haren, OT Idoko, JT Evans… - Frontiers in …, 2020 - frontiersin.org
Other than clean drinking water, vaccines have been the most effective public health
intervention in human history, yet their full potential is still untapped. To date, vaccine …